Lopicure 10 Tablet contains Atorvastatin 10 mg, a lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin works by inhibiting HMG-CoA reductase, a key enzyme involved in hepatic cholesterol synthesis, leading to upregulation of LDL receptors and enhanced clearance of LDL cholesterol from the bloodstream. This mechanism contributes to the reduction of atherosclerotic plaque formation and cardiovascular risk. Lopicure 10 is commonly prescribed for primary and secondary prevention of cardiovascular diseases, including coronary artery disease, stroke, and peripheral vascular disease, especially in patients with risk factors such as diabetes mellitus, hypertension, or a history of myocardial infarction. The recommended dosage should be individualized based on patient response and lipid profile, with regular monitoring of liver function tests and lipid levels advised during therapy. Patients should be counseled on lifestyle modifications including diet, exercise, and smoking cessation to optimize therapeutic outcomes. Potential adverse effects include myopathy, elevated liver enzymes, and gastrointestinal disturbances; prompt reporting of muscle pain or weakness is essential.